DERM Insider Trading Activity and SEC Form 4 Filings
DERM insider trading summary
No open-market insider purchases or sales of Journey Medical Corp (DERM) have been reported on SEC Form 4 in the past 12 months.
Latest DERM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 2, 2025 | Claude Maraoui | President & CEO | Sell | $33K (4,834 @ $6.84) |
| May 2, 2025 | Joseph Benesch | CFO | Sell | $16K (2,409 @ $6.84) |
| May 2, 2025 | Ramsey Alloush | COO | Sell | $20K (2,857 @ $6.84) |
| Mar 11, 2025 | Claude Maraoui | President & CEO | Sell | $247K (49,271 @ $5.01) |
| Mar 7, 2025 | Claude Maraoui | President & CEO | Sell | $75K (14,905 @ $5.01) |
| Mar 6, 2025 | Claude Maraoui | President & CEO | Sell | $129K (25,551 @ $5.04) |
| Mar 5, 2025 | Claude Maraoui | President & CEO | Sell | $93K (18,147 @ $5.13) |
| Mar 4, 2025 | Claude Maraoui | President & CEO | Sell | $146K (28,901 @ $5.04) |
| Mar 3, 2025 | Claude Maraoui | President & CEO | Sell | $122K (23,508 @ $5.19) |
| Feb 21, 2025 | Joseph Benesch | CFO | Sell | $7K (1,365 @ $5.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.